FitLife Brands Inc. (FTLF) exhibits 43.1% gross margins and 5.4% return on invested capital within Health Care (Medicinal Chemicals and Botanical Products), balanced against a 24.8x enterprise multiple and 4.8% implied options volatility.
Sustained 43.1% gross profitability converts into 18.6% operating margin and 5.4% ROIC, outpacing sector cost of capital.
ROIC: 5.4% // GM: 43.1%YoY revenue trajectory of — paired with 9.96% free cash flow yield supports self-funded R&D and capital return.
REV YOY: — // FCF YLD: 9.96%Altman Z-Score of 1.24 and Piotroski F-Score of 6/9 indicate low near-term refinancing stress.
ALTMAN Z: 1.24 // F-SCORE: 6/9Trading at 11.7x trailing P/E (10.9x Fwd P/E) leaves valuation vulnerable if real 10Y TIPS yields spike.
P/E: 11.7x // EV/EBITDA: 24.8xOptions market prices a ±5.2% implied move with a 0.85 put/call ratio around $7.91 max pain.
IMPL MOVE: ±5.2% // P/C: 0.85Elevated industry capital intensity and customer concentration in Medicinal Chemicals and Botanical Products require continuous execution to defend 39.7% net margins.
NET MARGIN: 39.7% // D/E: 0.45x| FILER | SIDE | $ VALUE |
|---|---|---|
| INSPECT FULL OWNERSHIP LEDGER IN OWN <GO> | ||
| STRIKE / EXP | TYPE | PREMIUM |
|---|---|---|
| INSPECT GEX & CHAIN IN OPT <GO> | ||
Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for FTLF & activate live FRED threshold breach alerts.